Daily Posts Archive
Facebook (FB) will report its latest quarterly results next Wednesday, April 27, after the market closes. And you can bet that people will be paying attention. When your company has a market cap of nearly $322 billion, a float of 2.2 billion shares, coverage from 49 analysts and over one billion active users per DAY (!), people tend to pay attention.
Although the markets wobbled a bit in anticipation of the Federal Reserve’s rate decision, the Dow Jones Industrial Average still managed to squeak out a 400+ point gain since our last issue.
Small cap gold stocks have been on fire in 2016. Many are up 50%, 100% or more. It hasn’t mattered much if the company is a profitable gold producer or a pre-revenue gold explorer. If it has anything to do with gold, it’s probably gone up. I monitor a watch list of small-cap gold stocks. And these five are up over 100% so far this year.
Options prices often rise as traders buy volatility/insurance to hedge against big moves or the unexpected.
In the 10 days since Tesla Motors (TSLA) unveiled the prototype of its Model 3 sedan, more than 325,000 people around the globe have put down $1,000 deposits for the car. That’s more than $325 million in Tesla’s coffers, which the company gets to keep for more than a year; deliveries of the $35,000 four-door sedan won’t begin until late next year.
The rule changes for financial advisors that came out on Wednesday created a modest stir in the financial industry. While there are over 1,000 pages in the new guidelines, the one change that hit a nerve was a requirement that anyone who gives investment advice for a fee has to act with the client’s best interests in mind.
Tesla stock is back on the rise thanks to its new Model 3 sedan, which is already a bigger seller than anyone expected.
Today, I want to describe a simple but powerful chart pattern that can help you identify low-risk entry points, or at the very least, inform you that the stock is acting properly. I’m talking about tightness in a stock price’s movement, and I’m seeing a lot of it these days.
One of the big stories this week was that the U.S. Treasury Department announced new rules that would limit companies’ ability to participate in inversions. The new rules put the Pfizer (PFE) and Allergen (AGN) merger in peril. And I took an interest in this because I had an open position in PFE, owning call options (a bullish position) since January.